Stupnisek et al., 2015) stabilize gastric pentadecapeptide BPC 157, which is effective in wound healing (Figures 16) (Seiwerth et al., 1997
Blue Fin Vision Medical Director Mr Mfazo Hove was invited to comment on the findings
It has also been studied in individuals with type 2 diabetes, where it may help reduce post-meal glucose levels
Ultimately, addressing fatigue while using GLP-1 medications involves understanding the side effects and taking proactive steps to improve quality of life
Used to study cellular growth, tissue repair, and regeneration processes
Current evidence from large-scale clinical trials and regulatory surveillance does not establish a causal link between GLP-1 receptor agonists and increased risk of venous thromboembolism (deep vein thrombosis or pulmonary embolism)